Dx Focus: Quidel RSV/hMPV Test Gets 510(k); Labceutics, Asuragen Partner on BCR-ABL1 Standardization
March 14, 2013
Dx Focus: Quidel RSV/hMPV Test Gets 510(k); Labceutics, Asuragen Partner on BCR-ABL1 Standardization
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA Clears Quidel's RSV, hMPV Molecular Assay
March 12, 2013 / GenomeWeb Daily News - Dx Focus: Enzo Files HCV Test with NYS; Quidel Gets CE Mark for RSV/hMPV Assay
March 15, 2012 / PCR Insider - Quidel Continues to Advance Trio of MDx Initiatives; On Target to Complete All by End of '13
March 1, 2012 / PCR Insider - Dx Focus: Quidel Gets FDA OK for First Pair of Molecular Tests
January 5, 2012 / PCR Insider - FDA OK of Life Tech, Quidel C. Diff Assay Sets Stage for Future Cleared Tests on QuantStudio Dx
March 21, 2013 / PCR Insider